Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Withdrawal of paracetamol in strong opioid-treated cancer pain patients
2020-005123-36Phase 3Active
- Sponsor
- Oslo University Hospital
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in metastasis comparing Paracetamol continuation arm with Paracetamol withdrawal (placebo) arm (2 arms). Primary endpoint: Average pain intensity. Started Apr 2021; status: active.
02
Drugs
acetaminophen
03
Conditions
metastasis
Beyond the preview
Go deeper on 2020-005123-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005123-36.